在脂肪组织新陈代谢中,高级甘氨酸终端产品 (RAGE) 途径的受体
Klaudia Gutowska1,2, Krzysztof Czajkowski1, Alina Kuryłowicz3,4
1II Faculty and Clinic of Obstetrics and Gynaecology, Medical University of Warsaw, 00-315 Warsaw, Poland.
International journal of molecular sciences
|July 14, 2023
概括
先进的糖化终产物 (AGEs) 通过AGE (RAGE) 路径的受体,促进与肥胖相关的脂肪组织功能障碍. 准这种途径为代谢并发症提供了治疗潜力.
科学领域:
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
- 细胞生物学 细胞生物学
背景情况:
- 先进的糖化终产物 (AGEs) 在高血糖期间与细胞功能障碍有关.
- 脂肪组织中AGE的积累有助于与肥胖有关的功能障碍.
- 对AGE的受体 (RAGE) 调解AGE对细胞内通路的影响.
研究的目的:
- 审查RAGE途径在肥胖中脂肪组织功能障碍中的作用.
- 探索RAGE通路在与肥胖相关的代谢并发症中的参与.
- 讨论针对RAGE路径的治疗策略.
主要方法:
- 现有科学文献的叙述性审查.
- AGE合成和RAGE信号通路的总结.
- 分析来自动物和人类研究的数据.
主要成果:
- 结合RAGE的AGE会影响脂肪细胞的分化,新陈代谢和分泌.
- RAGE通路参与肥胖,糖尿病和心血管疾病中的脂肪组织功能障碍.
- 有证据表明,RAGE通路干扰可能会恢复脂肪组织功能.
结论:
- RAGE通路是与肥胖相关的脂肪组织功能障碍的关键调解者.
- 针对AGE的产生,积累或RAGE信号提供了一个治疗途径.
- 干扰RAGE通路可能有助于对抗肥胖并发症.
相关概念视频
Insulin: The Receptor and Signaling Pathways
1.3K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.3K
cAMP-dependent Protein Kinase Pathways
6.4K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.4K
GPCRs Regulate Adenylyl Cylase Activity
5.7K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.7K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Global Regulatory Systems
44
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
44
PI3K/mTOR/AKT Signaling Pathway
3.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.7K


